Lupus patients get stem cell hope in expanded access trial
NCT ID NCT04907175
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study offers expanded access to a stem cell treatment called HB-adMSCs for people with systemic lupus erythematosus (SLE). It is designed for adults 18 and older who have their own stem cells stored at Hope Biosciences. The goal is to check if the treatment is safe and helps control lupus symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Female participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult individual 18 years of age or older. * Cognitively intact and capable of giving informed consent. * Clinical diagnosis of Systemic Lupus Erythematosus. * Subject has mesenchymal stem cells banked at Hope Biosciences. * The patient accepts to receive treatment and to comply with follow-up visits. Exclusion Criteria: * Clinically significant, uncontrolled cardiovascular, lung, renal, hepatic, or endocrine diseases that in the opinion of the investigator may increase the risks associated with study participation. * Active Alcohol or Drug addiction. * Participation in concurrent interventional research studies during this study. * Severe organ failure (heart, kidney or liver) confirmed by additional tests or medical history. * Unwillingness to return for follow-up visits.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for System; lupus erythematosus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.